The Defender Children’s Health Defense News and Views
Close menu
Close menu

You must be a CHD Insider to save this article Sign Up

Already an Insider? Log in

September 20, 2023

COVID News Watch

Fauci Making Millions During COVID Pandemic Sparks Backlash + More

The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines. The views expressed in the excerpts from other news sources do not necessarily reflect the views of The Defender.

COVID News Watch

Fauci Making Millions During COVID Pandemic Sparks Backlash

Newsweek reported:

Anthony Fauci, the White House’s chief medical adviser during the COVID-19 pandemic, and his wife saw their net worth go up $5 million from before the start of the health crisis through 2021, according to financial disclosures from the National Institutes of Health (NIH).

NIH financial records obtained by the website OpenTheBooks show that the couple’s net worth increased by approximately $5 million from 2019 through 2021, from about $7.6 million to over $12.6 million. Fauci and his wife, Christine Grady, a bioethicist who heads the Bioethics Department at the NIH Clinical Center, had a net worth that exceeded $11 million in 2022, according to the U.K.’s Daily Mail.

“During the pandemic years, the Faucis became deca-millionaires, with their household net worth exceeding $10 million,” OpenTheBooks CEO Adam Andrzejewski told Fox News. “Last year was a tough year in the markets. However, Fauci’s net worth is still up sharply from $7.6 million in 2019.”

Fauci is estimated to be collecting a federal pension that rivals a presidential salary, Andrzejewski added, calling it “the largest federal retirement package in history.”

The Anti-Vaccine Movement Is on the Rise. The White House Is at a Loss Over What to Do About It.

Politico reported:

A Biden administration that vowed to restore Americans’ faith in public health has grown increasingly paralyzed over how to combat the resurgence in vaccine skepticism.

And internally, aides and advisers concede there is no comprehensive plan for countering a movement that’s steadily expanded its influence on the president’s watch.

“There’s a real challenge here,” said one senior official who’s worked on the COVID response and was granted anonymity to speak candidly. “But they keep just hoping it’ll go away.” And the impact is clear: As another COVID vaccination campaign gets underway, fewer Americans than ever have kept up to date on their shots. Child vaccination rates against the flu are measurably lower than before the pandemic.

Even standard childhood inoculations to prevent diseases like measles are subject to deepening partisan divisions, with recent polling showing Republicans are now more than twice as likely to believe the shots should be optional than they did in 2019. Democrats, by contrast, remain overwhelmingly in favor of childhood vaccine requirements.

Northeastern Among Sites Chosen by CDC to Establish ‘National Weather Service’ for Infectious Disease

The Boston Globe via MSN reported:

Northeastern University has been selected for a leading role in a new national network formed to better forecast the spread of a future pandemic.

The university announced Tuesday the U.S. Centers for Disease Control and Prevention has awarded it $17.5 million over the next five years to develop a center focused on detecting and preparing for the next outbreak of infectious disease, especially in rural areas.

Alessandro Vespignani, director of Northeastern’s Network Science Institute, is leading the project, called “EPISTORM: The Center for Advanced Epidemic Analytics and Predictive Modeling Technology.”

The money comes through the CDC’s Center for Forecasting and Outbreak Analytics, which was formed last year with the goal, Vespignani said, of creating “what would be a National Weather Service for epidemic threats.” NU is among 13 centers in the CDC’s new outbreak response network. Boston University is a subcontractor working with NU.

U.S. Government Awards $45 Million for Long COVID Clinics

Reuters reported:

The U.S. government is awarding $45 million in grants to help clinics treating long COVID develop new models of care and expand access, the Department of Health and Human Services (HHS) said on Wednesday.

Nine clinics will receive $1 million in grants annually over the next five years through the Agency for Healthcare Research and Quality (AHRQ) within HHS, the department said.

President Joe Biden had tasked HHS last year with developing a national action plan to tackle long COVID, a complex, multi-symptom condition that arises months after a COVID-19 infection and leaves many of its sufferers unable to work.

The funding will be used for increasing in-person and virtual visits, establishing new satellite clinics, and an education initiative aimed at growing referrals. Limited knowledge and acceptance among clinicians have contributed to delays in diagnoses and referrals.

COVID Leveling Off in Some Areas of the Country, Despite Uptick in Cases

NBC News reported:

Wastewater data suggest that the recent uptick in COVID cases may have peaked, at least in some areas.

Biobot Analytics, a company that tracks wastewater samples at 257 sites nationwide, said that the current average COVID levels across the United States are approximately 5% lower than they were last week.

“All fingers crossed,” Cristin Young, a Biobot epidemiologist said, “this wave is plateauing and may be declining.”

After a mid- to late-summer rise, the CDC‘s COVID wastewater surveillance now shows declines in mid-Atlantic states, such as Virginia and Maryland. Wastewater collection sites in the Midwest and the Northeast, however, show a steady uptick in COVID spread.

Moderna to Cut mRNA Drug Substance Production at Lonza Facility

Reuters reported:

Moderna (MRNA.O) said on Tuesday it will cut production of mRNA drug substance for its COVID-19 vaccine at Lonza’s (LONN.S) facility in Switzerland this quarter as part of a plan to align manufacturing of the shots with lower post-pandemic demand.

The U.S. company had said last week it was in talks with its partners that fill vials and syringes globally to downsize vaccine production.

Such a move will help Moderna adjust to the sharp fall in demand for COVID vaccines as payers cut back orders for the shots, partly following the end of the public health emergency for the disease.

Suggest A Correction

Share Options

Close menu

Republish Article

Please use the HTML above to republish this article. It is pre-formatted to follow our republication guidelines. Among other things, these require that the article not be edited; that the author’s byline is included; and that The Defender is clearly credited as the original source.

Please visit our full guidelines for more information. By republishing this article, you agree to these terms.

Woman drinking coffee looking at phone

Join hundreds of thousands of subscribers who rely on The Defender for their daily dose of critical analysis and accurate, nonpartisan reporting on Big Pharma, Big Food, Big Chemical, Big Energy, and Big Tech and
their impact on children’s health and the environment.

  • This field is for validation purposes and should be left unchanged.
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
    MM slash DD slash YYYY
  • This field is hidden when viewing the form